Kane Biotech

More great news from Kane Biotech! 👏

Following a Letter of Intent signed by BioStem Technologies, Kane is excited to announce BioStem as our new U.S. distribution partner for our revyve™ Antimicrobial Wound Gel! Our team is thrilled to partner with BioStem and is eager to continue our mission of bringing access to innovative wound care solutions and enhancing patient outcomes across the U.S.

👉 Read the full press release: https://ir.kanebiotech.com/press-releases/detail/388/kane-biotech-announces-change-in-us-distribution-partner

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel Download as PDF November 27, 2024 BioStem Technologies Signs Letter of Intent to Acquire Exclusive US Distribution Rights for revyve™ from ProgenaCare Global WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWS...

Congratulations to the Kane research team on the publication of their article: “Wound Gel Formulations Containing Poloxamer 407 and Polyhexanide Have In Vitro Antimicrobial and Antibiofilm Activity Against Wound-Associated Microbial Pathogens.”

This achievement reflects our incredible team's expertise, dedication, and commitment to advancing knowledge in wound care. We’re proud to celebrate this milestone and look forward to the meaningful impact this work will have in the field!

Read the full article: https://www.mdpi.com/2076-2607/12/11/2362

We're pleased to announce that Kane Biotech's revyve™ Antimicrobial Wound Gel has been approved by Health Canada as a Class 2 Medical Device! 🙌

This is a huge achievement, and it wouldn't have been possible without the hard work of our dedicated team. We're excited to make revyve™ available to Canadians, bringing advanced wound care to those who need it most!

👉 Read the full article: https://www.globenewswire.com/news-release/2024/11/14/2981511/0/en/Kane-Biotech-Announces-Health-Canada-Approval-of-revyve-Antimicrobial-Wound-Gel.html

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that...

Thank you to the Winnipeg Free Press for featuring Kane Biotech’s commitment to making a positive impact through our donation of 2,000 ounces of revyve™ Antimicrobial Wound Gel to the Ukrainian medical relief effort. (Please note, the article mistakenly mentions 20,000 ounces; the correct amount is 2,000 ounces.)

👉 Read the full article: https://winnipeg-can.newsmemory.com/?publink=09739fd1c_134d4a4
👉 Read Kane’s full press release: https://ir.kanebiotech.com/press-releases/detail/383/kane-biotech-announces-donation-of-revyve-antimicrobial

Kane Biotech donates antimicrobial wound gel to Ukrainian war efforts MARTIN CASHKANE Biotech is donating up to 20,000 ounces of its antimic

Kane Biotech will be donating 2,000 ounces of our revyve™ Antimicrobial Wound Gel to aid in the Ukraine medical relief effort. Our goal is to make our product accessible to the people of Ukraine suffering from chronic wounds, in the hopes that we can do our part in helping to heal the many Ukrainian casualties.

Read the full press release: https://ir.kanebiotech.com/press-releases/detail/383/kane-biotech-announces-donation-of-revyve-antimicrobial

We're having an amazing time at the Wounds Canada Conference! Our team is proudly demoing the cutting-edge solutions from XSONX, LLC and our innovative revyve™ antimicrobial wound gel. The response has been overwhelmingly positive!

👉 Explore more about XSONX: https://xsonx.com/
👉 Learn more about revyve™: https://revyvegel.com/

Kane Biotech is pleased to announce we have signed an exclusive 5-year distribution agreement with XSONX, LLC to distribute XSONXS's Wound Hygiene System in Canada, Australia, New Zealand, and the Gulf Cooperation Council Countries.

Read the full press release: https://ir.kanebiotech.com/press-releases/detail/382/kane-biotech-announces-exclusive-distribution-agreement

Kane Biotech Announces Exclusive Distribution Agreement With XSONX Kane Biotech Announces Exclusive Distribution Agreement With XSONX Download as PDF October 17, 2024 WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution ag...